Map Key
Generic Enzyme
Generic kinase
Protein kinase
Lipid kinase
Generic phosphatase
Protein phosphatase
Lipid phosphatase
Generic phospholipase
Generic protease
Metalloprotease
G-alpha
RAS - superfamily
G beta/gamma
Regulators (GDI, GAP, GEF)
Generic channel
Ligand-gated channel
Voltage-gated channel
Transporter
Normal process
Pathological process
Positive effect
Negative effect
Unspecified effect
Technical link
Disrupts in disease
Emerges in disease
Enhances in disease
Weakens in disease
Organsim specific interaction

Generic binding protein
Receptor ligand
Cell membrane glycoprotein
Transcription factor
DNA
RNA
Compound
Inorganic ion
Predicted metabolite or user's structure
Reaction
Generic receptor
GPCR
Receptors with enzyme activity
Mitochondria
EPR
Golgi
Nucleus
Lysosome
Peroxisome
Cytoplasm
Extracellular

Normal process
Pathological process
Binding
Cleavage
Covalent modifications
Phosphorylation
Dephosphorylation
Transformation
Transport
Catalysis
Transcription regulation
MicroRNA binding
Competition
Influence on expression
Unspecified interactions
Pharmacological effect
Toxic effect
Group relation
Complex subunit
Similarity reaction
A complex or a group
Organism specific object

Immune response IL-2 activation and signaling pathway


Log In to Post A Comment

Immune response IL-2 activation and signaling pathway

IL-2 activation and signaling pathway

Interleukin-2 ( IL-2 ) is a T-Cell-derived cytokine important in the regulationof growth and differentiation of T-Cells, B-Cells, natural killer cells, glioma cells,and cells of the monocyte lineage.

IL-2 signaling is mediated by a multichain IL-2 receptor complexconsisting of an alpha ( IL-2R alpha chain ), beta ( IL-2R beta chain ) andgamma ( IL-2R gamma chain ) subunits. The IL-2R alpha chain primarilyincreases the affinity of ligand binding, whereas IL-2R beta chain and IL-2Rgamma chain participate in both ligand binding, and signal transduction [1].

IL-2 receptor activates several different pathways that mediate the flow ofmitogenic and survival-promoting signals [2].

Janus Kinases-1 and -3 ( JAK1 and JAK3 ) that are associated withIL-2R beta chain and IL-2R gamma chain, respectively, are activated afterbinding of IL-2 to its receptor [3], [4]. Phosphorylationof the cytoplasmic domains of IL-2 receptor provides docking sites for theJAK1 and JAK3. The latter autophosphorylate and provide docking sites forand phosphorylate Signal transducer and activator of transcription-5 ( STAT5A,STAT5 ). Phosphorylation induces dimerization and nuclear translocation ofSTAT5 complexes, where they promote transcription of specific target genes, e.g.,Cytokine inducible SH2-containing protein ( CISH ) that negatively modulatesSTAT5 activation [5], [1].

IL-2 receptor complex also binds Spleen tyrosine kinase ( Syk )and lymphocyte-specific protein tyrosine kinase ( Lck ) that are activateddownstream of JAK1 and JAK3, respectively [6]. Lck iscritical for the induction of c-Fos gene. Activation of Syk results in theinduction of the c-Myc gene. JAK3 is required for the induction of bothc-Fos and c-Myc genes [7], [8], [9],[10].

Suppressor of cytokine signaling 1 ( SOCS1 ) is an IL-2 -inducedinhibitor of IL-2 signaling that associates with JAK1 and inhibitsJAK1 kinase activity [11].

Protein tyrosine phosphatase, non-receptor type 6 ( SHP-1 ) dephosphorylatesJAK1 and acts as a negative regulator of IL-2 receptor/ JAK1signaling [12].

IL-2 receptor signaling also activates Phosphatidylinositol 3-kinase ( PI3Kreg class IA (p85)/ PI3K cat class IA ) which catalyzes phosphorylation ofPhosphatidylinositol-3,4,5-trisphosphate ( PtdIns(3,4,5)P3 ) [13]. Thissecond messenger recruits molecules such as 3-Phosphoinositide dependent protein kinase-1( PDK (PDPK1) ) and v-Akt murine thymoma viral oncogene homolog ( AKT ) tothe cell membrane [14], [15], [16]. AKTsignaling stimulates Nuclear factor-kappa B ( NF-kB ) activity by up-regulatingI-kappaB ( I-kB ) degradation via phosphorylation of I-kappaB kinase alpha (IKK-alpha ), a subunit of I-kappaB kinase complex ( IKK (cat) ), therebyallowing the transcription of NF-kB target genes, such as genes encoding proteinsinvolved in promoting cell survival, as well as transcription of IL-2R alpha chainand IL-2 itself [17], [18], [19], [20], [21].

IL-2 stimulates SHC (Src homology 2 domain containing) transforming protein 1 (Shc )/ Growth factor receptor-bound protein 2 ( GRB2 )/ Son of sevenlesshomologs ( SOS )/ v-Ha-ras Harvey rat sarcoma viral oncogene homolog (H-Ras )/ v-Raf-1 murine leukemia viral oncogene homolog 1 ( c-Raf-1 )/Mitogen-activated protein kinase kinase 1 and 2 ( MEK1 and MEK2 )/Extracellular signal-regulated kinase 1 and 2 ( ERK1/2 ) signaling [22]. This pathway induces activation of transcription factors, includingElk-1, c-Fos, c-Jun/c-Fos and AP-1 that play a criticalrole in IL-2 gene expression [23], [24], [25].

Protein tyrosine phosphatase, non-receptor type 11 ( SHP-2 ) associates withPI3K reg class IA (p85), GRB2 and GRB2-associated binding protein (GAB2 ), and activates ERK1/2 pathway [26], [27],[28].

IL-2 gene expression in antigen-activated T cells plays a critical role inorchestrating the immune responses. IL-2 gene expression is controlled at multiplelevels. In an autocrine fashion, the antigen-primed T helper cell secretes IL-2,stimulating itself as well as other neighboring T cells [17], [19],[29].

Up-regulation of IL-2 gene expression is also the major endpoint of signalingby the T cell antigen receptor (TCR). In normal T cells, engagement of TCR-CD3 complexesand costimulation by CD28 lead to the stimulation of multiple pathways followed byactivation of transcription factors, including NF-kB, nuclear factor of activatedT-cells cytoplasmic calcineurin-dependent 2 ( NF-AT1 ), Early growth response 1 (EGR1 ), E74-like factor 1 ( ELF1 ), Elk-1, c-Fos,c-Jun/c-Fos and AP-1. Together, NF-kB, NF -AT1,EGR1 ELF1, AP-1 and constitutively expressed POU class 2 homeobox 1( Oct-1 ) regulate the IL-2 proximal promoter to drive IL-2 genetranscription [30], [31], [29]. High mobility groupAT-hook 1 ( HMGI/Y ) can facilitate the formation of this functional complex oftranscription factors, activating IL-2 gene expression [32].

Transforming growth factor-beta (TGF-beta) suppresses IL-2 gene expression in Tcells via SMAD family ( SMAD3 and SMAD4 )-dependent signaling [33], [34], [35]. Transducer of ERBB2 1 ( Tob1 )associates with SMAD4 and exerts the inhibitory effect on IL-2transcription by enhancement of SMAD4 DNA-binding on the negative regulatoryelement of the IL-2 promoter [33].